Circulating Tumor Cells (CTC) Market Report

Global and Region Circulating Tumor Cells (CTC) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：145
  • REPORT CODE：GMM901811
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Circulating Tumor Cells is a collective term for all types of tumor cells present in the peripheral blood.CTC assays monitor trends in CTC type and number by capturing and detecting CTCs present in the peripheral blood to monitor tumor dynamics, assess treatment efficacy, and enable real-time individual therapy.

    The many potential applications of Circulating Tumor Cells in prediagnosis, pretreatment, and during and after treatment offer lucrative growth opportunities for participants involved in the development of Circulating Tumor Cells enrichment and isolation products. The global circulating tumor cells market is expected to reach USD 9.6 billion by 2025. The continued growth of the Circulating Tumor Cells market in North America can be attributed to the presence of active players such as Advanced Cell Diagnostics. These market players are adopting various strategies to enhance their market share. For instance, in November 2019, Biocept, Inc. initiated the Target Selector pan-TRK assay to identify TRK proteins. The assay, based on the company's circulating tumor cell platform, detects TRK gene alterations in blood samples. These initiatives have increased the availability of cost-effective, non-invasive biomarker assays for cancer detection in the country. Moreover, high population susceptibility to cancer, increasing market penetration, and technologically advanced cancer care infrastructure are some of the key factors accounting for its huge share. On the other hand, Asia Pacific is expected to grow at a considerable rate owing to the highly unmet diagnostic needs and rapidly growing patient awareness regarding early detection and risk assessment of cancer.

    Growing demand for effective diagnostic and screening tests and technological advancements in cancer detection is expected to drive the growth of the Circulating Tumor Cells market. The high adoption of concomitant diagnostics for monitoring the tumor characteristics of cytotoxic drugs for elimination is one of the factors driving the Circulating Tumor Cells market demand. Key stakeholders have been working on the development of circulating tumor cell based tests that may help in cancer diagnosis. The growing development of microarray technology is another key factor driving the growth of the circulating tumor cells market.

    The report details the trend, potential and market size of Circulating Tumor Cells (CTC) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Tumor Cells (CTC)market, defines the market attractiveness level of Circulating Tumor Cells (CTC) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Circulating Tumor Cells (CTC) industry, describes the types of Circulating Tumor Cells (CTC) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Tumor Cells (CTC) market and the development prospects and opportunities of Circulating Tumor Cells (CTC) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Tumor Cells (CTC) market in Chapter 13.

    By Player:

    • Agilent Technologies, Inc

    • Thermo Fisher Scientific, Inc

    • Abbott

    • Illumina, Inc

    • General Electric

    • Siemens Healthcare GmbH

    • FHoffmann-La Roche Ltd

    • Bio-Rad Laboratories, Inc

    • Toshiba Corporation

    • Koninklijke Philips NV

    By Type:

    • CTC Detection & Enrichment Methods

    • CTC Direct Detection Methods

    • CTC Analysis

    By End-User:

    • Clinical/Liquid Biopsy

    • Research

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Circulating Tumor Cells (CTC) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Circulating Tumor Cells (CTC) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Circulating Tumor Cells (CTC) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Circulating Tumor Cells (CTC) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Circulating Tumor Cells (CTC) Market Analysis and Outlook to 2022

    • 7.1 Global Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.2 United States Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.3 Europe Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.4 China Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.5 Japan Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.6 India Circulating Tumor Cells (CTC) Consumption (2017-2022)

    • 7.7 South Korea Circulating Tumor Cells (CTC) Consumption (2017-2022)

    8 Region and Country-wise Circulating Tumor Cells (CTC) Market Analysis and Outlook to 2028

    • 8.1 Global Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.2 United States Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.3 Europe Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.4 China Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.5 Japan Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.6 India Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    • 8.7 South Korea Circulating Tumor Cells (CTC) Consumption Forecast (2022-2028)

    9 Global Circulating Tumor Cells (CTC) Market Outlook by Types and Applications to 2022

    • 9.1 Global Circulating Tumor Cells (CTC) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CTC Detection & Enrichment Methods Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTC Direct Detection Methods Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CTC Analysis Consumption and Growth Rate (2017-2022)

    • 9.2 Global Circulating Tumor Cells (CTC) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinical/Liquid Biopsy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Consumption and Growth Rate (2017-2022)

    10 Global Circulating Tumor Cells (CTC) Market Outlook by Types and Applications to 2028

    • 10.1 Global Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CTC Detection & Enrichment Methods Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CTC Direct Detection Methods Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinical/Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Consumption Forecast and Growth Rate (2022-2028)

    11 Global Circulating Tumor Cells (CTC) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Circulating Tumor Cells (CTC) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Circulating Tumor Cells (CTC) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Circulating Tumor Cells (CTC) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Circulating Tumor Cells (CTC) Market Competitive Analysis

    • 14.1 Agilent Technologies, Inc

      • 14.1.1 Agilent Technologies, Inc Company Details

      • 14.1.2 Agilent Technologies, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Agilent Technologies, Inc Circulating Tumor Cells (CTC) Product and Service

    • 14.2 Thermo Fisher Scientific, Inc

      • 14.2.1 Thermo Fisher Scientific, Inc Company Details

      • 14.2.2 Thermo Fisher Scientific, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Thermo Fisher Scientific, Inc Circulating Tumor Cells (CTC) Product and Service

    • 14.3 Abbott

      • 14.3.1 Abbott Company Details

      • 14.3.2 Abbott Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Abbott Circulating Tumor Cells (CTC) Product and Service

    • 14.4 Illumina, Inc

      • 14.4.1 Illumina, Inc Company Details

      • 14.4.2 Illumina, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Illumina, Inc Circulating Tumor Cells (CTC) Product and Service

    • 14.5 General Electric

      • 14.5.1 General Electric Company Details

      • 14.5.2 General Electric Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 General Electric Circulating Tumor Cells (CTC) Product and Service

    • 14.6 Siemens Healthcare GmbH

      • 14.6.1 Siemens Healthcare GmbH Company Details

      • 14.6.2 Siemens Healthcare GmbH Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Siemens Healthcare GmbH Circulating Tumor Cells (CTC) Product and Service

    • 14.7 FHoffmann-La Roche Ltd

      • 14.7.1 FHoffmann-La Roche Ltd Company Details

      • 14.7.2 FHoffmann-La Roche Ltd Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 FHoffmann-La Roche Ltd Circulating Tumor Cells (CTC) Product and Service

    • 14.8 Bio-Rad Laboratories, Inc

      • 14.8.1 Bio-Rad Laboratories, Inc Company Details

      • 14.8.2 Bio-Rad Laboratories, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bio-Rad Laboratories, Inc Circulating Tumor Cells (CTC) Product and Service

    • 14.9 Toshiba Corporation

      • 14.9.1 Toshiba Corporation Company Details

      • 14.9.2 Toshiba Corporation Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Toshiba Corporation Circulating Tumor Cells (CTC) Product and Service

    • 14.10 Koninklijke Philips NV

      • 14.10.1 Koninklijke Philips NV Company Details

      • 14.10.2 Koninklijke Philips NV Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Koninklijke Philips NV Circulating Tumor Cells (CTC) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Circulating Tumor Cells (CTC)

    • Figure Circulating Tumor Cells (CTC) Picture

    • Table Global Circulating Tumor Cells (CTC) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells (CTC) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells (CTC) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Circulating Tumor Cells (CTC) Consumption by Country (2017-2022)

    • Figure United States Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Table Europe Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Figure China Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Figure Japan Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Figure India Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Circulating Tumor Cells (CTC) Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells (CTC) Consumption Forecast by Country (2022-2028)

    • Figure United States Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Circulating Tumor Cells (CTC) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Detection & Enrichment Methods Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Direct Detection Methods Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Clinical/Liquid Biopsy Consumption and Growth Rate (2017-2022)

    • Figure Global Research Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Detection & Enrichment Methods Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Direct Detection Methods Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinical/Liquid Biopsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Circulating Tumor Cells (CTC) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Circulating Tumor Cells (CTC) Export by Region (Top 5 Countries) (2017-2028)

    • Table Agilent Technologies, Inc (Foundation Year, Company Profile and etc.)

    • Table Agilent Technologies, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies, Inc Circulating Tumor Cells (CTC) Product and Service

    • Table Thermo Fisher Scientific, Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific, Inc Circulating Tumor Cells (CTC) Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Circulating Tumor Cells (CTC) Product and Service

    • Table Illumina, Inc (Foundation Year, Company Profile and etc.)

    • Table Illumina, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina, Inc Circulating Tumor Cells (CTC) Product and Service

    • Table General Electric (Foundation Year, Company Profile and etc.)

    • Table General Electric Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table General Electric Circulating Tumor Cells (CTC) Product and Service

    • Table Siemens Healthcare GmbH (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare GmbH Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare GmbH Circulating Tumor Cells (CTC) Product and Service

    • Table FHoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table FHoffmann-La Roche Ltd Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann-La Roche Ltd Circulating Tumor Cells (CTC) Product and Service

    • Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories, Inc Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories, Inc Circulating Tumor Cells (CTC) Product and Service

    • Table Toshiba Corporation (Foundation Year, Company Profile and etc.)

    • Table Toshiba Corporation Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toshiba Corporation Circulating Tumor Cells (CTC) Product and Service

    • Table Koninklijke Philips NV (Foundation Year, Company Profile and etc.)

    • Table Koninklijke Philips NV Circulating Tumor Cells (CTC) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Koninklijke Philips NV Circulating Tumor Cells (CTC) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US